Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MK0594 in Overactive Bladder
NCT00290563Phase 2Completed
- Sponsor
- Vyne Therapeutics
- Start
- Feb 2006
- Primary completion
- Aug 2007
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of serlopitant in overactive bladder (OAB), sponsored by Vyne Therapeutics. Started Feb 2006; status: completed.
02
Drugs
serlopitant
03
Conditions
overactive bladder (OAB)
Beyond the preview
Go deeper on NCT00290563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00290563.